PRME vs. HIMS
PRME (Prime Medicine Inc. Common Stock) and HIMS (Hims & Hers Health, Inc.) are both stocks. PRME operates in Biotechnology (Healthcare), while HIMS operates in Household & Personal Products (Consumer Defensive). Over the past 3 years, PRME returned -42.02%/yr vs 45.13%/yr for HIMS. At a 0.31 correlation, their price movements are largely independent.
Performance
PRME vs. HIMS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, PRME achieves a -9.51% return, which is significantly higher than HIMS's -15.28% return.
PRME
- 1D
- -2.18%
- 1M
- -9.51%
- YTD
- -9.51%
- 6M
- -13.02%
- 1Y
- 136.09%
- 3Y*
- -42.02%
- 5Y*
- —
- 10Y*
- —
HIMS
- 1D
- 0.00%
- 1M
- 0.88%
- YTD
- -15.28%
- 6M
- -25.79%
- 1Y
- -49.74%
- 3Y*
- 45.13%
- 5Y*
- 14.51%
- 10Y*
- —
PRME vs. HIMS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
PRME Prime Medicine Inc. Common Stock | -9.51% | 18.84% | -67.04% | -52.31% | 20.88% |
HIMS Hims & Hers Health, Inc. | -15.28% | 34.28% | 171.69% | 38.85% | 49.77% |
Correlation
The correlation between PRME and HIMS is 0.37, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.37 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.34 |
Correlation (All Time) Calculated using the full available price history since Oct 21, 2022 | 0.31 |
Fundamentals
PRME:
$556.08M
HIMS:
$6.28B
PRME:
-$1.29
HIMS:
-$0.05
PRME:
152.05
HIMS:
2.85
PRME:
7.25
HIMS:
14.08
PRME:
$3.18M
HIMS:
$2.37B
PRME:
-$4.14M
HIMS:
$1.70B
PRME:
-$195.72M
HIMS:
$16.04M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PRME vs. HIMS — Risk / Return Rank
PRME
HIMS
PRME vs. HIMS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Prime Medicine Inc. Common Stock (PRME) and Hims & Hers Health, Inc. (HIMS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| PRME | HIMS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.90 | ||
| Sortino ratioReturn per unit of downside risk | +2.74 | ||
| Omega ratioGain probability vs. loss probability | 1.25 | 0.96 | +0.29 |
| Calmar ratioReturn relative to maximum drawdown | 2.30 | -0.64 | +2.94 |
| Martin ratioReturn relative to average drawdown | 3.78 | -1.06 | +4.84 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| PRME | HIMS | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.38 | -0.52 | +1.90 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | 0.18 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.40 | 0.22 | -0.61 |
Drawdowns
PRME vs. HIMS - Drawdown Comparison
The maximum PRME drawdown since its inception was -94.55%, which is greater than HIMS's maximum drawdown of -87.29%. Use the drawdown chart below to compare losses from any high point for PRME and HIMS.
Loading charts...
Drawdown Indicators
| PRME | HIMS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -94.55% | -87.29% | -7.26% |
Max Drawdown (1Y)Largest decline over 1 year | -59.52% | -78.06% | +18.54% |
Max Drawdown (3Y)Largest decline over 3 years | -93.26% | -78.88% | -14.38% |
Max Drawdown (5Y)Largest decline over 5 years | — | -79.74% | — |
Current DrawdownCurrent decline from peak | -85.13% | -59.98% | -25.15% |
Average DrawdownAverage peak-to-trough decline | -65.32% | -43.19% | -22.13% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 36.12% | 47.08% | -10.96% |
Volatility
PRME vs. HIMS - Volatility Comparison
The current volatility for Prime Medicine Inc. Common Stock (PRME) is 21.20%, while Hims & Hers Health, Inc. (HIMS) has a volatility of 25.84%. This indicates that PRME experiences smaller price fluctuations and is considered to be less risky than HIMS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| PRME | HIMS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 21.20% | 25.84% | -4.64% |
Volatility (6M)Calculated over the trailing 6-month period | 52.94% | 66.58% | -13.64% |
Volatility (1Y)Calculated over the trailing 1-year period | 99.57% | 95.97% | +3.60% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 89.75% | 83.37% | +6.38% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 89.75% | 77.20% | +12.55% |
Dividends
PRME vs. HIMS - Dividend Comparison
Neither PRME nor HIMS has paid dividends to shareholders.
Financials
PRME vs. HIMS - Financials Comparison
This section allows you to compare key financial metrics between Prime Medicine Inc. Common Stock and Hims & Hers Health, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
PRME and HIMS have a correlation of 0.37, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
HIMS has higher volatility (25.84%) compared to PRME (21.20%). In terms of maximum drawdown, PRME dropped -94.55% vs HIMS's -87.29%.
PRME currently has the higher Sharpe Ratio (1.38 vs -0.52), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for PRME and HIMS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer